نتائج البحث - Isabel Arrillaga
- يعرض 1 - 20 نتائج من 22
- اذهب إلى الاصفحة التالية
-
1
-
2
-
3
A phase 2 study of the first imipridone ONC201, a selective DRD2 antagonist for oncology, administered every three weeks in recurrent glioblastoma حسب Isabel Arrillaga‐Romany, S. Andrew, Joshua E. Allen, Wolfgang Oster, Patrick Y. Wen, Tracy T. Batchelor
منشور في 2017Artigo -
4
-
5
Current status of the cryopreservation of embryogenic material of woody species حسب Daniel Ballesteros, María Teresa Martínez, Carolina Sánchez‐Romero, Itziar A. Montalbán, Ester Sales, Paloma Moncaleán, Isabel Arrillaga, Elena Corredoira
منشور في 2024Artigo -
6
-
7
-
8
Modulatory Effects of Modafinil on Neural Circuits Regulating Emotion and Cognition حسب Roberta Rasetti, Venkata S. Mattay, Beth Stankevich, Kelsey Skjei, Giuseppe Blasi, Fabio Sambataro, Isabel Arrillaga‐Romany, Terry E. Goldberg, Joseph H. Callicott, José Apud, Daniel R. Weinberger
منشور في 2010Artigo -
9
Biological activity of weekly ONC201 in adult recurrent glioblastoma patients حسب Isabel Arrillaga‐Romany, Yazmín Odia, Varun V. Prabhu, Rohinton S. Tarapore, Krystal Merdinger, Martin Stogniew, Wolfgang Oster, Joshua E. Allen, Minesh P. Mehta, Tracy T. Batchelor, Patrick Y. Wen
منشور في 2019Artigo -
10
Pharmacodynamics of mutant-IDH1 inhibitors in glioma patients probed by in vivo 3D MRS imaging of 2-hydroxyglutarate حسب Ovidiu C. Andronesi, Isabel Arrillaga‐Romany, Ina Ly, Wolfgang Bogner, Eva Ratai, Kara Reitz, A. John Iafrate, Jörg Dietrich, Elizabeth R. Gerstner, S. Andrew, Bruce R. Rosen, Patrick Y. Wen, Daniel P. Cahill, Tracy T. Batchelor
منشور في 2018Artigo -
11
ACTION: a randomized phase 3 study of ONC201 (dordaviprone) in patients with newly diagnosed H3 K27M-mutant diffuse glioma حسب Isabel Arrillaga‐Romany, Andrew B. Lassman, Susan L. McGovern, Sabine Mueller, Burt Nabors, Martin J. van den Bent, Michael A. Vogelbaum, Joshua E. Allen, Allen S. Melemed, Rohinton S. Tarapore, Patrick Y. Wen, Timothy F. Cloughesy
منشور في 2024Artigo -
12
Clinical presentation, management, and biomarkers of neurotoxicity after adoptive immunotherapy with CAR T cells حسب Philipp Karschnia, Justin T. Jordan, Deborah Forst, Isabel Arrillaga‐Romany, Tracy T. Batchelor, Joachim M. Baehring, Nathan F. Clement, L. Nicolas Gonzalez Castro, Aline Herlopian, Marcela V. Maus, Michaela H. Schwaiblmair, Jacob D. Soumerai, Ronald W. Takvorian, Ephraim P. Hochberg, Jeffrey A. Barnes, Jeremy S. Abramson, Matthew J. Frigault, Jörg Dietrich
منشور في 2019Artigo -
13
Individualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT): A Bayesian Adaptive Platform Trial to Develop Precision Medicines for Patients With Glioblastoma حسب Brian M. Alexander, Lorenzo Trippa, Sarah Gaffey, Isabel Arrillaga‐Romany, Eudocia Q. Lee, Mikael L. Rinne, Manmeet S. Ahluwalia, Howard Colman, Geoffrey Fell, Evanthia Galanis, John de Groot, Jan Drappatz, Andrew B. Lassman, David M. Meredith, Burt Nabors, Sandro Santagata, David Schiff, Mary Welch, Keith L. Ligon, Patrick Y. Wen
منشور في 2019Artigo -
14
Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial حسب Ingo K. Mellinghoff, Min Lu, Patrick Y. Wen, Jennie Taylor, Elizabeth A. Maher, Isabel Arrillaga‐Romany, Katherine B. Peters, Benjamin M. Ellingson, Marc K. Rosenblum, Saewon Chun, Kha Le, Anna M. Tassinari, Sung Choe, Youssef Toubouti, Steven Schoenfeld, Shuchi S. Pandya, Islam Hassan, Lori Steelman, Jennifer Clarke, Timothy F. Cloughesy
منشور في 2023Artigo -
15
Dopamine Receptor D5 is a Modulator of Tumor Response to Dopamine Receptor D2 Antagonism حسب Varun V. Prabhu, Neel S. Madhukar, Coryandar Gilvary, C. Leah B. Kline, Sophie Oster, Wafik S. El‐Deiry, Olivier Elemento, Faye Doherty, Alexander VanEngelenburg, Jessica Durrant, Rohinton S. Tarapore, Sean Deacon, Neil Charter, Jinkyu Jung, Deric M. Park, Mark R. Gilbert, Jessica M. Rusert, Robert J. Wechsler‐Reya, Isabel Arrillaga‐Romany, Tracy T. Batchelor, Patrick Y. Wen, Wolfgang Oster, Joshua E. Allen
منشور في 2018Artigo -
16
Phase 2 study of pembrolizumab in patients with recurrent and residual high-grade meningiomas حسب Priscilla K. Brastianos, Albert E. Kim, Anita Giobbie‐Hurder, Eudocia Q. Lee, Nancy Wang, April F. Eichler, Ugonma Chukwueke, Deborah Forst, Isabel Arrillaga‐Romany, Jörg Dietrich, Zachary Corbin, Jennifer Moliterno, Joachim M. Baehring, Michael G. White, Kevin Lou, Juliana M. Larson, Magali de Sauvage, Kathryn Evancic, Joana L. Mora, Naema Nayyar, Jay S. Loeffler, Kevin Oh, Helen A. Shih, William T. Curry, Daniel P. Cahill, Fred G. Barker, Elizabeth R. Gerstner, Sandro Santagata
منشور في 2022Artigo -
17
Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma حسب Timothy F. Cloughesy, Aaron Mochizuki, Joey Orpilla, Willy Hugo, Alex Lee, Tom B. Davidson, Anthony Wang, Benjamin M. Ellingson, Julie Rytlewski, Catherine Sanders, Eric S. Kawaguchi, Lin Du, Gang Li, William H. Yong, Sarah Gaffey, Adam L. Cohen, Ingo K. Mellinghoff, Eudocia Q. Lee, David A. Reardon, Barbara O’Brien, Nicholas Butowski, Phioanh L. Nghiemphu, Jennifer Clarke, Isabel Arrillaga‐Romany, Howard Colman, Thomas Kaley, John de Groot, Linda M. Liau, Patrick Y. Wen, Robert M. Prins
منشور في 2019Artigo -
18
ONC201 (Dordaviprone) in Recurrent H3 K27M–Mutant Diffuse Midline Glioma حسب Isabel Arrillaga‐Romany, Sharon L. Gardner, Yazmín Odia, Dolly Aguilera, Joshua E. Allen, Tracy T. Batchelor, Nicholas Butowski, Clark C. Chen, Timothy F. Cloughesy, Andrew Cluster, John de Groot, Karan Dixit, Jerome Graber, Aya Haggiagi, Rebecca A. Harrison, Albert Kheradpour, Lindsay Kilburn, Sylvia C. Kurz, Guangrong Lu, Tobey J. MacDonald, Minesh P. Mehta, Allen S. Melemed, Phioanh L. Nghiemphu, Samuel Ramage, Nicole Shonka, Ashley Sumrall, Rohinton S. Tarapore, Lynne P. Taylor, Yoshie Umemura, Patrick Y. Wen
منشور في 2024Artigo -
19
Mutant IDH inhibitors induce lineage differentiation in IDH-mutant oligodendroglioma حسب Avishay Spitzer, Simon Gritsch, Masashi Nomura, Alexander Jucht, Jérôme Fortin, Ramya Raviram, Hannah Weisman, L. Nicolas Gonzalez Castro, Nicholas Druck, Rony Chanoch-Myers, John J. Y. Lee, Ravindra Mylvaganam, Rachel L. Servis, Jeremy Man Fung, Christine K. Lee, Hiroaki Nagashima, Julie J. Miller, Isabel Arrillaga‐Romany, David N. Louis, Hiroaki Wakimoto, Will Pisano, Patrick Y. Wen, Tak W. Mak, Marc Sanson, Mehdi Touat, Dan A. Landau, Keith L. Ligon, Daniel P. Cahill, Mario L. Suvà, Itay Tirosh
منشور في 2024Artigo -
20
Validation of postoperative residual contrast-enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma حسب Benjamin M. Ellingson, Lauren E. Abrey, Sarah J. Nelson, Timothy J. Kaufmann, Josep Garcia, Olivier Chinot, Frank Saran, Ryo Nishikawa, Roger Henriksson, W. P. Mason, Wolfgang Wick, Nicholas Butowski, Keith L. Ligon, Elizabeth R. Gerstner, Howard Colman, John de Groot, Susan M. Chang, Ingo K. Mellinghoff, Robert J. Young, Brian M. Alexander, Rivka R. Colen, Jennie Taylor, Isabel Arrillaga‐Romany, Arnav Mehta, Raymond Y. Huang, Whitney B. Pope, David A. Reardon, Tracy T. Batchelor, Michael D. Prados, Evanthia Galanis, Patrick Y. Wen, Timothy F. Cloughesy
منشور في 2018Artigo
أدوات البحث:
موضوعات ذات صلة
Medicine
Internal medicine
Biology
Cancer research
Gene
Genetics
Oncology
Glioma
Mutant
Biochemistry
Cancer
Chemotherapy
Clinical endpoint
Clinical trial
Receptor
Surgery
IDH1
Radiation therapy
Cell biology
Chemistry
Enzyme
Gene expression
Immunotherapy
Neuroscience
Pathology
Pharmacology
Randomized controlled trial
Urology
Amygdala
Antagonist